Literature DB >> 18546341

Cognitive dysfunction in Nigerians with Parkinson's disease.

Rufus O Akinyemi1, Njideka N Okubadejo, Joshua O Akinyemi, Mayowa O Owolabi, Lukman F Owolabi, Adesola Ogunniyi.   

Abstract

Despite the original description of Parkinson's disease (PD) as a disorder in which "the senses and intellect remain uninjured," there is now sufficient evidence that cognitive dysfunction does occur. This research determined the frequency, pattern, and predictors of cognitive dysfunction among 51 Nigerian patients with PD compared with 50 demographically matched controls using the modified Community Screening Instrument for Dementia (CSI'D') and selected items from the Ibadan Neuropsychological Battery (I-NB). In all, 21.6% patients with PD (4% of controls) exhibited cognitive impairment (P = 0.008) defined, for the purposes of this study, as total modified CSI'D' score below 2 SD of the mean score of the control group. Cognitive dysfunction in patients with PD encompassed memory, language, and executive dysfunction. Correlates of cognitive dysfunction included older age at PD onset (P = 0.001), older current age (P < 0.001), and higher UPDRS motor score (P = 0.005). After logistic regression, older age at onset of PD was the only independent predictor of cognitive dysfunction. (O.R = 1.29; 95% CI = 1.08-1.57, P = 0.006). Cognitive dysfunction occurs more frequently in Nigerians with PD compared to controls. Older age at disease onset is an important determinant of cognitive dysfunction in PD. Copyright 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2008        PMID: 18546341     DOI: 10.1002/mds.22087

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

Review 1.  Parkinson's disease in Nigeria: A review of published studies and recommendations for future research.

Authors:  Oluwafemi G Oluwole; Helena Kuivaniemi; Jonathan A Carr; Owen A Ross; Matthew O B Olaogun; Soraya Bardien; Morenikeji A Komolafe
Journal:  Parkinsonism Relat Disord       Date:  2018-12-08       Impact factor: 4.891

Review 2.  Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors:  Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

Review 3.  Neuroscience in Nigeria: the past, the present and the future.

Authors:  Wasiu Gbolahan Balogun; Ansa Emmanuel Cobham; Abdulbasit Amin
Journal:  Metab Brain Dis       Date:  2017-10-09       Impact factor: 3.584

Review 4.  Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Tolulope Oyeniyi; Bruce Ovbiagele; Donna K Arnett; Hemant K Tiwari; Richard Walker; Adesola Ogunniyi; Raj N Kalaria
Journal:  J Neurol Sci       Date:  2016-05-06       Impact factor: 3.181

5.  Frequency of cognitive impairment and depression in Parkinson's disease: A preliminary case-control study.

Authors:  Oluwadamilola O Ojo; Njideka U Okubadejo; Frank I Ojini; Mustapha A Danesi
Journal:  Niger Med J       Date:  2012-04

6.  The Accessibility of Parkinson's Disease Medication in Kenya: Results of a National Survey.

Authors:  Jolynne Mokaya; Catherine L Dotchin; William K Gray; Juzar Hooker; Richard W Walker
Journal:  Mov Disord Clin Pract       Date:  2016-01-09

7.  Clinical profile of parkinsonian disorders in the tropics: Experience at Kano, northwestern Nigeria.

Authors:  Owolabi Lukman Femi; A Ibrahim; S Aliyu
Journal:  J Neurosci Rural Pract       Date:  2012-09

8.  Epidemiology of Parkinsonism and Parkinson's disease in Sub-Saharan Africa: Nigerian profile.

Authors:  Rufus O Akinyemi
Journal:  J Neurosci Rural Pract       Date:  2012-09

9.  Effect of vinpocetine (cognitol™) on cognitive performances of a nigerian population.

Authors:  Ao Ogunrin
Journal:  Ann Med Health Sci Res       Date:  2014-07

10.  Falls and Their Associated Risks in Parkinson's Disease Patients in Nigeria.

Authors:  Temitope Hannah Farombi; Mayowa O Owolabi; Adesola Ogunniyi
Journal:  J Mov Disord       Date:  2016-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.